About 4 million people in the United States might have hepatitis C, says the Centers for Disease Control and Prevention1. This virus attacks the liver and is a big reason for liver failure and liver transplants2. It’s a big health issue, and experts suggest all adults 18 to 79 should get tested, even if they feel fine2.
Hepatitis C comes from the hepatitis C virus and spreads through blood contact2. There are seven types worldwide, with type 1 being the most common in the U.S2.. If it becomes chronic, it can cause serious problems like liver cirrhosis, liver cancer, and liver failure2.
Key Takeaways
- Hepatitis C is a viral infection that affects the liver, leading to inflammation and potential liver damage.
- Nearly 4 million people in the United States may have hepatitis C, with rates of infection quadrupling in the last decade.
- Chronic hepatitis C can result in serious complications, including liver cirrhosis, liver cancer, and liver failure.
- The U.S. Preventive Services Task Force recommends screening all adults aged 18 to 79 for hepatitis C, even without symptoms.
- Hepatitis C is primarily transmitted through contact with infected blood, such as sharing needles or unsterilized medical equipment.
What is Hepatitis C?
Hepatitis C is a viral infection that mainly affects the liver. It causes inflammation and swelling, which can harm the liver over time3. This virus is one of the top causes of liver failure and liver transplants in the U.S3.
The infection can turn into a chronic condition. If not treated, it can lead to cirrhosis and liver cancer3. The CDC says 2.7 million to 3.9 million people in the U.S. have chronic hepatitis C3. About 75 to 85 percent of people with acute hepatitis C will get chronic hepatitis C3.
The virus spreads through contact with infected blood, like sharing needles or unclean medical tools4. Since 2006, new cases have risen, especially in young people who use heroin or misuse opioids3. Experts think hepatitis C could become rare in the U.S. by 2036 with better screening and treatment3.
| Hepatitis C Genotypes | Percentage in the U.S. |
|---|---|
| Genotype 1 | The most common genotype in the U.S2. |
| Genotypes 2, 3, 4, 5, and 6 | Less common in the U.S2. |
Hepatitis C is the most common chronic viral infection spread through blood contact in the U.S3. Without treatment, it can lead to cirrhosis, liver failure, or liver cancer3.
“Hepatitis C is a viral infection that affects the liver, causing inflammation and swelling that can damage liver tissues over time. It is one of the leading causes of liver failure and liver transplantation in the United States.”
In summary, hepatitis C is a serious viral infection that targets the liver. It can cause inflammation, swelling, and long-term liver damage if not treated. Knowing about this disease and its spread in the U.S. helps in early detection and management342.
Prevalence of Hepatitis C
Hepatitis C is a big health issue in the U.S. The CDC says 2.7 million to 3.9 million people might have it5. Every year, 17,000 new cases pop up, and 75% of those with it don’t even know they have it5.
Some groups are more likely to get it. For example, 75% of those with it were born between 1945 and 19655. Also, about 2.2 million adults aged 18 and up had it in 2017-2020, and many didn’t know they had it6.
It hits hard on those without insurance or living in poverty. People without insurance or below the poverty line had much higher rates than those with insurance or above poverty6.
Worldwide, 58 million people have hepatitis C virus (HCV). The number of people testing positive for HCV went up from 2.3% to 2.8% from 1990 to 20057. In rich countries, about 1 to 2% have it7.
With so many cases and not enough awareness, it’s key to screen and detect it early. This can prevent serious liver damage and help people stay healthier. The CDC now suggests screening all U.S. adults, not just those at high risk5.
Cause of hepatitis c
Hepatitis C is caused by the hepatitis C virus (HCV), mainly spread through infected blood8. In the U.S., most people get it from sharing needles for injecting drugs8. Before 1992, it was often spread through blood transfusions and organ transplants. But now, thanks to better blood screening, this is rare8.
Sharing needles for drugs is a big risk, but so is getting it from an infected mom during birth8. Sadly, many people with hepatitis C don’t show symptoms. If not treated, it can lead to serious liver problems8.
There are medicines that can cure hepatitis C, but no vaccine yet8. To prevent it, avoid sharing needles, wear gloves when handling blood, and use clean tools for tattoos and piercings8. Safe sex practices also help8.
Prevalence of Hepatitis C
From 2017 to 2020, 2.4 to 4 million people in the U.S. had hepatitis C9. The number of new cases went down in 2022, but it’s still high among some groups9. About half of new cases were linked to injecting drugs9.
Half of people with hepatitis C might clear the virus on their own, but chronic cases are a big concern9. Chronic hepatitis C is a top cause of liver cancer and liver transplants9. The CDC now suggests testing for all adults and those at risk to help treat it9.
“Chronic hepatitis C is a leading cause of liver cancer and the main reason for liver transplants in the United States.”
In April 2020, the CDC made testing easier to help fight hepatitis C9. In July 2023, they advised testing babies and kids born to infected moms9.
2.4 million people in the U.S. have hepatitis C, and most will keep it for years10. Chronic hepatitis C can cause serious health issues, like liver cancer, years later10. If not treated, it can severely damage the liver10.
The CDC wants everyone 18 and older to get tested for hepatitis C at least once10. Since 1992, all blood and organs in the U.S. are checked for hepatitis C10. New treatments can cure hepatitis C in over 95% of cases, often in just a few weeks1089.
Differences Between Hepatitis A, B, and C
Hepatitis A, B, and C are all viral infections that affect the liver. They differ in how they spread and their effects on the body11. Hepatitis A is usually a short illness, but B and C can become long-term problems if not treated12. Knowing the differences helps doctors diagnose and treat these infections correctly.
Hepatitis A is caused by the hepatitis A virus and spreads through contaminated food or water12. It usually heals in 1-3 weeks and doesn’t turn into a chronic condition12. Hepatitis B, on the other hand, is caused by the hepatitis B virus and spreads through blood or body fluids, like during childbirth11. It can cause a lifelong infection and increase the risk of liver disease12.
Hepatitis C is caused by the hepatitis C virus and spreads through sharing needles or getting stuck with a needle in a medical setting, or from an infected mother to her baby during birth11. Unlike Hepatitis A, Hepatitis C often becomes a long-term infection, affecting about 75-85% of people12. If not treated, it can lead to serious liver problems over time12.
| Characteristic | Hepatitis A | Hepatitis B | Hepatitis C |
|---|---|---|---|
| Causative Virus | Hepatitis A Virus (HAV) | Hepatitis B Virus (HBV) | Hepatitis C Virus (HCV) |
| Primary Transmission | Contaminated food or water | Contact with infected blood or body fluids, including during childbirth | Sharing needles or “works” when “shooting” drugs, needlestick or sharps exposures in a healthcare setting, or from an infected mother to her baby during vaginal birth |
| Potential for Chronic Infection | Short-term illness, does not lead to chronic infection | Can cause lifelong infection with a risk of liver disease later in life | Can lead to chronic infections, with an estimated 75–85% of people with acute hepatitis C developing a chronic form of the disease |
| Vaccine Availability | Vaccine available | Vaccine available | No vaccine currently available, although research is ongoing |
In summary, hepatitis A, B, and C are all liver infections with different causes and effects131112. Understanding these differences is key for proper diagnosis, treatment, and prevention.
Stages of Hepatitis C Infection
Hepatitis C is a complex viral infection that goes through different stages. Each stage has its own characteristics and effects. Knowing about these stages helps in managing and treating the disease effectively.
Incubation Period
The first stage of hepatitis C is the incubation period, lasting from 2 weeks to 6 months. During this time, the virus spreads in the body but the infected person may not show any symptoms14.
Acute Infection
After the incubation period, the acute infection stage starts. Most people with hepatitis C won’t show symptoms during this stage. But, about 20% might develop acute hepatitis C14.
Chronic Infection
Most people with hepatitis C move to a chronic infection. This happens to 75% to 85% of those infected14. If not treated, chronic hepatitis C can cause liver damage and cirrhosis over many years1415.
- About 70% of people with hepatitis C get chronic hepatitis C15.
- 15–30% of those with chronic hepatitis C may get cirrhosis of the liver in 20 years15.
- 5–25 out of every 100 people with hepatitis C could get cirrhosis in 10–20 years15.
Chronic hepatitis C can last a lifetime if not treated14. Symptoms are often not clear, with fatigue being a common one14.
How hepatitis C progresses can vary a lot from person to person. Early detection and proper management are key to preventing long-term liver damage and complications16.
hepatitis c Transmission
Hepatitis C spreads mainly through infected blood, often from sharing needles or equipment for injecting drugs17. This is the main way people get hepatitis C in the U.S18.. It can also spread through unclean medical tools, blood transfusions or organ transplants before tests were done, and rarely from an infected mom to her baby during pregnancy or birth19.
Sexual transmission of hepatitis C is rare among couples who only have sex with each other17. But, people with many sexual partners, who have had STDs, or have HIV might be more likely to get the virus18. Healthcare workers who get stuck with needles are also at higher risk17.
Some groups are more likely to get hepatitis C. Those born between 1945 and 1965, or who got clotting factor concentrates before 1987, or had blood transfusions or organ transplants before July 1992, are at higher risk17. People with HIV and those in jail or prison are also more likely to get it17.
Using safe injection methods, making sure medical tools are clean, and avoiding risky behaviors like using drugs or getting tattoos without proper safety are key to stopping hepatitis C from spreading1819.
Since there’s no vaccine, finding and treating hepatitis C early can help prevent serious liver damage19. Knowing how hepatitis C spreads and taking steps to prevent it can keep people safe and help fight this serious liver disease.
Symptoms of Hepatitis C
Hepatitis C is often called the “silent epidemic” because it can hide in the body for years without showing symptoms20. About 1 in every 3 or 4 people with hepatitis C will show symptoms in the first 6 months20. But, most people with acute hepatitis C don’t show any symptoms at all20.
The real challenge is with the chronic form of hepatitis C21. About 55–85% of people who get HCV will get chronic hepatitis C21. This chronic infection can silently harm the liver for years, often without clear symptoms21. Symptoms like bleeding, bruising, and fluid buildup in the abdomen may show up only when the liver is severely damaged21.
Chronic symptoms of hepatitis C include fatigue, joint and muscle pain, nausea, cognitive difficulties, mood swings, depression, indigestion, itching, and abdominal pain2. These symptoms can greatly affect a person’s life and may not show up until the disease is advanced2.
The silent nature of hepatitis C is why the CDC recommends screening all U.S. adults for the virus, even if they don’t show symptoms2. Early detection and treatment are key to preventing long-term liver damage and complications from chronic hepatitis C infection.
“Hepatitis C can often lurk in the body for years without any noticeable symptoms, making it a silent epidemic. Regular screening is essential for early detection and treatment.”
Diagnosis and Testing
Diagnosing hepatitis C is a two-step process. First, a test looks for antibodies to the hepatitis C virus (anti-HCV)22. If this test comes back positive, a second test checks for the virus itself (HCV RNA)22. This second test is key because about 30% of people with anti-HCV antibodies have actually beaten the virus and don’t need treatment22.
These two tests together help doctors accurately diagnose and manage hepatitis C2223. The Centers for Disease Control and Prevention (CDC) say all adults 18 and older should get tested for hepatitis C at least once23. Pregnant women should also get tested during each pregnancy23.
The CDC also suggests testing for people with certain risks, like those who have used drugs23. For those possibly exposed to HCV in the past 6 months, testing for HCV RNA is recommended22. The CDC also wants all HCV antibody tests to include HCV RNA testing to catch more cases22.
The National Notifiable Diseases Surveillance System tracks cases of hepatitis C22. Reporting cases to health authorities helps with quick action and response22.
| Hepatitis C Screening Recommendations | Diagnostic Tests |
|---|---|
Getting an accurate diagnosis and testing on time is key to managing hepatitis C well. By following guidelines and using the right tests, doctors can quickly find and treat this serious liver disease23.
“Hepatitis C is a leading cause of liver failure and liver transplantation in the United States. Early diagnosis and appropriate treatment are essential to prevent long-term complications and improve patient outcomes.”
Treatment for Hepatitis C
The treatment for hepatitis C has changed a lot in recent years. New medicines called direct-acting antivirals (DAAs) have changed how we treat the disease. These medicines, like sofosbuvir and daclatasvir, can cure over 95% of people in 8-12 weeks2526.
The main goal of treatment is to get rid of the virus and prevent liver damage. This includes cirrhosis and liver cancer25. Thanks to these new medicines, getting rid of the virus is much more likely26.
Hepatitis C Treatment Options
In the UK, the NHS offers many DAA drugs for hepatitis C. These include sofosbuvir, ledipasvir-sofosbuvir, and others26. The right treatment plan depends on the patient’s genotype, liver health, and past treatments.
| Hepatitis C Medication | Genotypes Treated | Treatment Duration | Cure Rate | Side Effects |
|---|---|---|---|---|
| Sofosbuvir (Sovaldi) | 1, 2, 3, 4, 5, 6 | 12-24 weeks | 90%+ | Headache, fatigue |
| Ledipasvir-Sofosbuvir (Harvoni) | 1, 4, 5, 6 | 8-12 weeks | 95%+ | Tiredness, headache, stomach pain |
| Glecaprevir-Pibrentasvir (Mavyret) | 1, 2, 3, 4, 5, 6 | 8-16 weeks | 97-98% | Headache, fatigue, diarrhea, nausea |
Most people find these treatments easy to handle, but some might feel a bit tired, have headaches, or feel sick26. Remember, getting better doesn’t mean you can’t get the virus again. You can still get infected26.
Research is always improving hepatitis C treatments. Getting tested and using these new treatments can cure hepatitis C and lower the risk of liver problems2527.
“Direct-acting antivirals can cure more than 95% of people in just 8–12 weeks, which is a remarkable achievement in the treatment of hepatitis C.”
Prevention of Hepatitis C
There is no vaccine yet to prevent hepatitis C, but there are steps to lower the risk. These steps include avoiding contact with infected blood, using safe injection methods, and getting help for those who inject drugs28. These actions are key to preventing this chronic liver disease29.
Avoid Contact with Infected Blood
Hepatitis C spreads mainly through blood with the virus29. So, it’s important to be careful. Avoid sharing needles, getting tattoos or piercings from unclean sources, or having sex without a condom29.
Utilize Safe Injection Practices
If you inject drugs, use clean needles and equipment28. Throw away used equipment properly and don’t share needles or other items related to drugs29.
Access Harm Reduction Services
Programs like needle exchanges and safe injection sites help prevent hepatitis C28. They give people who inject drugs clean needles, teach safe use, and connect them with health services29.
Even without a vaccine, these steps are vital to fight hepatitis C28. By focusing on safety, we can all help stop the spread of this disease30.
“Early diagnosis and treatment of hepatitis C can help prevent or limit liver damage and transmission of the infection to others.”30
| Prevention Measure | Description |
|---|---|
| Avoid Contact with Infected Blood | Be cautious when engaging in activities that could expose you to infected blood, such as sharing drug preparation equipment, receiving unsterile tattoos or piercings, or having condomless sexual contact. |
| Utilize Safe Injection Practices | For people who inject drugs, use sterile needles, syringes, and other injection equipment, and avoid sharing any drug-related paraphernalia. |
| Access Harm Reduction Services | Utilize harm reduction programs, such as needle exchange services and supervised injection facilities, which provide sterile equipment, education, and referrals to healthcare resources. |
By taking these steps, we can greatly lower our risk of getting or spreading hepatitis C. This is a key step in fighting this health issue283029.
Impact of Hepatitis C on Health
Hepatitis C is a serious viral infection that can harm your health if not treated31. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says up to 3.9 million people in the U.S. might have chronic hepatitis C31. Globally, the World Health Organization (WHO) reports 58 million people have chronic hepatitis C31.
This virus causes chronic inflammation and damage to the liver. This can lead to cirrhosis (severe liver scarring), liver failure, and liver cancer31. Research shows 15–30% of those with chronic hepatitis C may develop liver failure31. Over 50% of people who get hepatitis C will have it for a long time, as stated by the Centers for Disease Control and Prevention (CDC)31.
Untreated hepatitis C can cause severe liver damage, liver cancer, and liver failure over time31. Cirrhosis, a result of HCV infection, can cause symptoms like easy bruising, jaundice, confusion, and forgetfulness31. It can also lead to circulatory problems, such as portal hypertension and variceal bleeding31.
Hepatitis C can affect the skin, causing easy bruising, loss of skin pigment, rashes, itching, and jaundice due to poor liver function31. It can also affect the endocrine system, causing hyperthyroidism, hypothyroidism, and increasing the risk of autoimmune thyroiditis and thyroid cancer31.
The long-term effects of hepatitis C highlight the need for early diagnosis and treatment31. Early action can prevent life-threatening conditions and improve health for those affected by this virus31.
Liver Damage and Cirrhosis
Chronic hepatitis C can severely harm the liver. The virus causes inflammation that leads to scar tissue in the liver, known as cirrhosis32. This scar tissue makes the liver less able to work right, causing serious health problems32.
Cirrhosis is a big worry for those with chronic hepatitis C32. In the U.S., hepatitis C is the top reason for liver transplants32. The virus slowly damages the liver over years, moving from inflammation to scarring that can’t be fixed32.
As cirrhosis gets worse, the liver can’t do its job, leading to liver failure32. Signs of liver disease include bleeding easily, jaundice, itching, stomach pain, losing appetite, nausea, swelling, and trouble focusing and remembering things32.
Cirrhosis also raises the chance of getting liver cancer32. The only cure for severe liver disease is a liver transplant32. But, the virus often comes back after a transplant32.
It’s key to treat hepatitis C early to stop liver damage32. Starting treatment early can lower the risk of cirrhosis and its problems32.
“The hepatitis C virus slowly damages the liver over many years, often progressing from inflammation to permanent, irreversible scarring (cirrhosis).”32
The Burden of Hepatitis C-Related Liver Damage
From 1999 to 2002, about 1.6% of people in the U.S. had hepatitis C virus33. Experts worry about the health issues that will come from chronic hepatitis C in the future33. They suggest finding and treating people born between 1945 and 1965 for hepatitis C33.
More people died from viral hepatitis in the U.S. from 1999 to 200733. Studies look at how many people will get sick, die, and what it will cost in the future33. They also studied how treatments like pegylated interferon alfa-2b and ribavirin affect liver damage33.
Stopping and managing hepatitis C-related liver damage is key to lessening the health burden333234.
Barriers to Treatment Access
Even though there are effective treatments for hepatitis C, many people can’t get them35. The cost of these treatments is very high, from $83,000 to $153,00035. Also, about 3.5 million people in the U.S. have hepatitis C, showing how big the problem is35.
Many people don’t know much about hepatitis C, and there’s a lot of stigma around it36. This makes people hesitant to get tested or treated36. In one study, only 5% of people in a big city got treatment36. Mental health and drug use issues often stop people from getting treatment36.
Healthcare systems also make it hard to get treatment35. Many patients have their Medicaid payments denied, even after trying to appeal35. This is a big problem for people with public insurance and those who are already vulnerable35.
Doctors and healthcare workers also face a big challenge. They spend a lot of time trying to get treatments approved35. In one case, a patient’s doctor spent 4 hours just on this35. Another case took 40 hours to get through all the steps, and a third needed 20 hours and many appeals35.
We need to make changes in policies, give more money, and teach people more to help everyone get the care they need35. It’s important to overcome these obstacles to fight this serious disease35.
“Hepatitis C is a serious disease that can lead to life-threatening complications, yet many patients face significant barriers to accessing the treatments that can cure it. Addressing these barriers is essential to improving health outcomes and reducing the burden of this disease.”
Hepatitis C Care and Service Delivery
Recently, big steps have been made in hepatitis C care and treatment services. New medications have made treatment easier, letting non-specialist doctors and nurses help more with hepatitis C37.
Testing and treatment are now easier to get in places like harm reduction programs and prisons. This makes it easier for patients to get help37. These new ways of delivering services and making treatments cheaper are key to helping more people with hepatitis C worldwide.
For these efforts to work, healthcare teams and health groups need to check in with the community before starting a new program. They should do this every year37. They need to look at who hasn’t been tested or treated for HCV and find out how common the disease is in the area37.
It’s also important to know what health groups suggest for testing and treating HCV. They should find out who can give these services, like doctors, peer groups, and drug treatment centers37. Making sure workers have the right technology is key to making these programs work37.
| Metric | Value |
|---|---|
| Proportion of Asian Americans tested for hepatitis B virus (HBV) | Fewer than 50%38 |
| Infants immunized against HBV within 3 days of birth | 72.4%38 |
| HEDIS measures used to monitor performance in American health plans | 90%38 |
| Potential preventable cases of myocardial infarctions, strokes, and end-stage renal disease with compliance to HEDIS measures | Almost 2 million, 800,000, and 100,000 respectively38 |
| Sensitivity and specificity of point-of-care tests for HCV core antigen | Greater than 90% and 98% respectively38 |
| Children meeting the goal of full immunization against HBV during the first 2 years of life | Over 90%38 |
| Increase in the proportion of children receiving the hepatitis B vaccine within the first 3 days of life from 2007 to 2014 | 53.2% to 72.4%38 |
These efforts to improve hepatitis C service delivery and treatment access are vital. They help fight the growing health issue of hepatitis C in the U.S. and globally37.
“Rates of acute HCV infections more than tripled among reproductive-aged persons in the United States during 2010–2021, increasing from 0.8 to 2.5 per 100,000 population among those aged 20–29 years and from 0.6 to 3.5 among those aged 30–39 years.”39
The rise in hepatitis C among young adults shows we need new, focused ways to help them. We must create hepatitis C care and service delivery models that meet their needs39.
By using these new methods and strategies, healthcare teams and health groups can boost hepatitis C treatment access. This can lessen the disease’s impact on people, communities, and healthcare systems37.
Conclusion
Hepatitis C is a serious viral infection that mainly affects the liver. If not treated, it can be very dangerous. But, thanks to new medicines, most people can get better40.
These new medicines help cure over 98% of HCV patients40. Yet, some people can’t get these treatments because of high costs and lack of knowledge41. In the U.S., about 1% of people, or 2.4 million, had hepatitis C from 2013 to 201641.
We can beat this disease by making sure more people get the care they need40. The World Health Organization aims to cut new HCV cases by 90% by 203040. With better treatments and prevention, we can manage and even stop hepatitis C. This would help everyone, from patients to the healthcare system.
In short, here are the main points about hepatitis C: it’s treatable with new medicines, but getting those medicines is hard for some; in the U.S., about 2.4 million people have it; and with the right approach, we can wipe out this disease. By learning more and tackling these issues, we can make a healthier future without hepatitis C.
FAQ
What is Hepatitis C?
How prevalent is Hepatitis C in the United States?
What causes Hepatitis C?
How does Hepatitis C differ from Hepatitis A and B?
What are the stages of Hepatitis C infection?
How is Hepatitis C transmitted?
What are the symptoms of Hepatitis C?
How is Hepatitis C diagnosed?
How is Hepatitis C treated?
How can Hepatitis C be prevented?
What are the long-term effects of untreated Hepatitis C?
What are the barriers to Hepatitis C treatment access?
How is Hepatitis C care and treatment services being improved?
Source Links
- Hepatitis C: Symptoms, What it Is, Transmission & Treatment – https://my.clevelandclinic.org/health/diseases/15664-hepatitis-c
- Hepatitis C – Symptoms and causes – https://www.mayoclinic.org/diseases-conditions/hepatitis-c/symptoms-causes/syc-20354278
- Hepatitis C – NIDDK – https://www.niddk.nih.gov/health-information/liver-disease/viral-hepatitis/hepatitis-c
- Hepatitis C – https://www.health.ny.gov/diseases/communicable/hepatitis/hepatitis_c/
- Hepatitis C (HCV) – Symptoms, Causes & Treatments – https://liverfoundation.org/liver-diseases/viral-hepatitis/hepatitis-c/
- Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017–March 2020 – https://academic.oup.com/cid/article/77/10/1413/7220839
- Hepatitis C – StatPearls – NCBI Bookshelf – https://www.ncbi.nlm.nih.gov/books/NBK430897/
- Hepatitis C | HCV | MedlinePlus – https://medlineplus.gov/hepatitisc.html
- Hepatitis C Basics – https://www.cdc.gov/hepatitis-c/about/index.html
- Hepatitis C – https://www.webmd.com/hepatitis/digestive-diseases-hepatitis-c
- The A, B, Cs of Viral Hepatitis – https://www.health.ny.gov/diseases/communicable/hepatitis/
- The Difference Between Hepatitis A, B and C | Hepatitis NSW – https://www.hep.org.au/blog/difference-between-hepatitis-a-b-c/
- Hepatitis B vs. hepatitis C: Differences and which is worse – https://www.medicalnewstoday.com/articles/323455
- Hepatitis C Stages and Progression – https://www.webmd.com/hepatitis/hepatitis-c-stages-progression
- Hepatitis C Stages: Acute, Chronic, End, and More – https://www.healthline.com/health/hepatitis-c/stages-progression
- Hepatitis C – https://fehv.org/en/diseases/hepatitis-c/
- Hepatitis C Transmission: How Hep C Is Spread & Contracted – https://www.webmd.com/hepatitis/hepatitis-c-protecting-others
- VA.gov | Veterans Affairs – https://www.hepatitis.va.gov/hcv/background/transmission-modes.asp
- Hepatitis C Prevention and Control – https://www.cdc.gov/hepatitis-c/prevention/index.html
- Hepatitis C – Symptoms – https://www.nhs.uk/conditions/hepatitis-c/symptoms/
- Hepatitis C: Symptoms, Causes, Risk Factors, and More – https://www.healthline.com/health/hepatitis-c
- Clinical Screening and Diagnosis for Hepatitis C – https://www.cdc.gov/hepatitis-c/hcp/diagnosis-testing/index.html
- Testing for Hepatitis C – https://www.cdc.gov/hepatitis-c/testing/index.html
- Hepatitis C – Diagnosis and treatment – Mayo Clinic – https://www.mayoclinic.org/diseases-conditions/hepatitis-c/diagnosis-treatment/drc-20354284
- Treatment of Hepatitis C – https://www.cdc.gov/hepatitis-c/treatment/index.html
- Hepatitis C – Treatment – https://www.nhs.uk/conditions/hepatitis-c/treatment/
- The Latest in Hep C Treatment – https://www.webmd.com/hepatitis/understanding-hepatitis-c-treatment
- Hepatitis C Basics – https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-c-basics/index.html
- Hepatitis C: Prevention and risks – https://www.canada.ca/en/public-health/services/diseases/hepatitis-c/prevention-risks.html
- Hepatitis C – https://www.nhs.uk/conditions/hepatitis-c/
- The Effects of Hepatitis C on Your Body – https://www.healthline.com/health/hepatitis-c/effects-on-the-body
- Hepatitis C: What happens in end-stage liver disease? – https://www.mayoclinic.org/diseases-conditions/hepatitis-c/expert-answers/hepatitis-c/faq-20058533
- Hepatitis C cirrhosis: New perspectives for diagnosis and treatment – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506942/
- Hepatitis C – Complications – https://www.nhs.uk/conditions/hepatitis-c/complications/
- Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678961/
- BARRIERS TO HEPATITIS C TREATMENT – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955982/
- Hepatitis C Care Navigation – INHSU – https://www.inhsu.org/intervention/hepatitis-c-care-navigation/
- Service Delivery – A National Strategy for the Elimination of Hepatitis B and C – https://www.ncbi.nlm.nih.gov/books/NBK442219/
- CDC Recommendations for Hepatitis C Testing … – https://www.cdc.gov/mmwr/volumes/72/rr/rr7204a1.htm
- Breakthroughs in hepatitis C research: from discovery to cure – Nature Reviews Gastroenterology & Hepatology – https://www.nature.com/articles/s41575-022-00608-8
- CDC Recommendations for Hepatitis C Screening Among Adults … – https://www.cdc.gov/mmwr/volumes/69/rr/rr6902a1.htm